SG11201604484UA - Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain - Google Patents

Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain

Info

Publication number
SG11201604484UA
SG11201604484UA SG11201604484UA SG11201604484UA SG11201604484UA SG 11201604484U A SG11201604484U A SG 11201604484UA SG 11201604484U A SG11201604484U A SG 11201604484UA SG 11201604484U A SG11201604484U A SG 11201604484UA SG 11201604484U A SG11201604484U A SG 11201604484UA
Authority
SG
Singapore
Prior art keywords
indansulfamide
pain
therapeutic
derivative
preventive agent
Prior art date
Application number
SG11201604484UA
Other languages
English (en)
Inventor
Hiroyuki Higashiyama
Yuji Kazuta
Keisuke Hashimoto
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of SG11201604484UA publication Critical patent/SG11201604484UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SG11201604484UA 2013-12-19 2014-12-17 Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain SG11201604484UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013262743 2013-12-19
PCT/JP2014/083374 WO2015093515A1 (ja) 2013-12-19 2014-12-17 1-インダンスルファミド誘導体を含む疼痛の治療および/または予防剤

Publications (1)

Publication Number Publication Date
SG11201604484UA true SG11201604484UA (en) 2016-07-28

Family

ID=53402860

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201604484UA SG11201604484UA (en) 2013-12-19 2014-12-17 Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain

Country Status (14)

Country Link
US (1) US9610262B2 (enrdf_load_stackoverflow)
EP (1) EP3085369B1 (enrdf_load_stackoverflow)
JP (1) JP6518595B2 (enrdf_load_stackoverflow)
KR (1) KR102250214B1 (enrdf_load_stackoverflow)
CN (1) CN105792821B (enrdf_load_stackoverflow)
AU (1) AU2014367781B2 (enrdf_load_stackoverflow)
BR (1) BR112016012833B1 (enrdf_load_stackoverflow)
CA (1) CA2932529C (enrdf_load_stackoverflow)
ES (1) ES2673876T3 (enrdf_load_stackoverflow)
IL (1) IL246036B (enrdf_load_stackoverflow)
MX (1) MX370898B (enrdf_load_stackoverflow)
RU (1) RU2678571C1 (enrdf_load_stackoverflow)
SG (1) SG11201604484UA (enrdf_load_stackoverflow)
WO (1) WO2015093515A1 (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020009100A (es) 2018-03-20 2020-12-03 Eisai R&D Man Co Ltd Agente de tratamiento de la epilepsia.
TW202345782A (zh) 2022-04-27 2023-12-01 日商衛材R&D企管股份有限公司 帕金森氏症治療用醫藥組成物
KR102815521B1 (ko) 2022-11-11 2025-06-04 덕산에테르씨티 주식회사 내화성능 및 강도가 보강된 압력용기
KR102803991B1 (ko) 2022-11-11 2025-05-13 덕산에테르씨티 주식회사 내화성능 및 강도가 보강된 압력용기
KR102815520B1 (ko) 2022-11-11 2025-06-04 덕산에테르씨티 주식회사 내화성능 및 강도가 보강된 압력용기
KR20250063587A (ko) 2023-11-01 2025-05-08 덕산에테르씨티 주식회사 압력 용기의 숄더부 보호용 커버
KR20250063589A (ko) 2023-11-01 2025-05-08 덕산에테르씨티 주식회사 압력 용기의 숄더부 보호용 커버
KR20250063588A (ko) 2023-11-01 2025-05-08 덕산에테르씨티 주식회사 압력 용기의 숄더부 보호용 커버

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070191452A1 (en) 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain
CL2007002994A1 (es) 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明(cyclopamine)類似物類
CA2758105A1 (en) * 2009-04-09 2010-10-14 N.V. Organon Indane derivatives
TW201217312A (en) 2010-09-22 2012-05-01 Gruenenthal Gmbh Substituted benzamide compounds
RU2508295C2 (ru) * 2012-03-22 2014-02-27 Общество с ограниченной ответственностью "Биофармокс" Синтетические пептиды с ненаркотическим типом анальгетического действия
SI2865663T1 (sl) 2012-06-21 2017-07-31 Eisai R&D Management Co., Ltd. Novi derivati indansulfamida

Also Published As

Publication number Publication date
BR112016012833A2 (enrdf_load_stackoverflow) 2017-08-08
KR102250214B1 (ko) 2021-05-07
IL246036A0 (en) 2016-07-31
CA2932529C (en) 2022-03-22
US20160303058A1 (en) 2016-10-20
JPWO2015093515A1 (ja) 2017-03-23
BR112016012833B1 (pt) 2022-11-16
KR20160106053A (ko) 2016-09-09
AU2014367781A1 (en) 2016-06-23
RU2678571C1 (ru) 2019-01-30
EP3085369A1 (en) 2016-10-26
EP3085369A4 (en) 2017-05-10
MX370898B (es) 2020-01-09
CA2932529A1 (en) 2015-06-25
EP3085369B1 (en) 2018-04-04
AU2014367781B2 (en) 2019-07-04
WO2015093515A1 (ja) 2015-06-25
RU2016122189A (ru) 2018-01-24
IL246036B (en) 2018-11-29
US9610262B2 (en) 2017-04-04
ES2673876T3 (es) 2018-06-26
CN105792821A (zh) 2016-07-20
CN105792821B (zh) 2018-05-04
MX2016007370A (es) 2016-10-03
JP6518595B2 (ja) 2019-05-22

Similar Documents

Publication Publication Date Title
IL279617B (en) Apparatus and methods for steaming embroidery
IL286759A (en) Therapeutic methods and preparations
PT2991600T (pt) Micro-oclusões e métodos relacionados para o tratamento da pele
GB201320729D0 (en) Therapeutic compounds and their use
ZA201506487B (en) Therapeutic compounds and compositions
HUE042081T2 (hu) Gyógyászati készítmény rák kezelésére és/vagy megelõzésére
IL244014A0 (en) Combined therapy for the treatment of glioblastoma
IL246036A0 (en) A therapeutic and/or prophylactic substance containing a derivative of 1-indensulfamide for pain
IL239921A0 (en) Preparations containing solutions in solid state and their use for the treatment of pain
EP2952149A4 (en) THERAPEUTIC TREATMENT DEVICE
GB201311361D0 (en) Compounds and their therapeutic use
SG10201710538XA (en) Compositions and methods for treating skin
ZA201603118B (en) Compounds for use in prevention and treatment of neurodegenerative diseases and pain
GB201309375D0 (en) Medical methods and compounds for medical use
GB201308736D0 (en) Compounds and their therapeutic use
ZA201601152B (en) Therapeutic agent for dyslipidemia
GB201410954D0 (en) Skin treatment devices and methods
EP3040084A4 (en) THERAPEUTIC FOR ECTOCORNEA INJURY
GB201317804D0 (en) Therapeutic compounds and their use
GB201316173D0 (en) Compounds and their therapeutic use
GB201307677D0 (en) Compounds and their therapeutic use
ZA201303790B (en) Formulation useful for treating pain and/or inflammation
GB201319255D0 (en) Therapeutic compositions and methods
GB201309379D0 (en) Medical methods and compounds for medical use
GB201309376D0 (en) Medical methods and compounds for medical use